Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Filed by W STRATEGIES, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2026
Income
$60,000.00
Expenses
Not reported
Filing UUID
067b83fb-891e-47c1-815c-7becf1fbbadb
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Public Law 119-21: One Big Beautiful Bill Act. Implementation of H.R.5376 Inflation Reduction Act. PBM reform legislation. 340(b) reform. FY 2027 National Defense Authorization Act. Issues around drug pricing including CMMI drug demonstration projects.

Literal federal measure citations: H.R.5376

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.